Market Closed -
Other stock markets
|
Pre-market 08:19:29 am | |||
25.74 USD | -0.35% |
|
25.82 | +0.31% |
Feb. 07 | AbbVie Gets FDA Approval of Intravenous Antibiotic Emblaveo | DJ |
Feb. 07 | US FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections | RE |
Consensus | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
$31.04 | +20.59% | 22 | |||||||
$979.86 | +11.56% | 26 | |||||||
DKK 827.79 | +31.63% | 24 | |||||||
$168.64 | +10.14% | 21 | |||||||
$204.9 | +7.5% | 27 | |||||||
CHF 307.34 | +6.35% | 19 | |||||||
GBX 173.84 | +20.84% | 19 | |||||||
$118.8 | +36.11% | 24 | |||||||
CHF 114.73 | +7.73% | 20 | |||||||
$316.7 | +7.89% | 26 | |||||||
€116.62 | +12.83% | 22 | |||||||
$101.24 | +5.41% | 25 | |||||||
$61.34 | +7.9% | 21 | |||||||
¥7,510 | +8.49% | 15 | |||||||
GBX 18.04 | +25.05% | 19 | |||||||
¥6,216.67 | +62.19% | 18 | |||||||
¥4,777.35 | +15.48% | 17 | |||||||
GBX 3.993 | +5.24% | 17 | |||||||
CN¥59.81 | +32.05% | 16 | |||||||
Average | 1,163.62 | +17.63% | 21 | ||||||
Weighted average by Cap. | 675.13 | +15.48% | 23 |
- Stock Market
- Equities
- PFE Stock
- Sector Pfizer, Inc.
- Sector consensus